4
Changes in Ownership
Artiva Biotherapeutics, Inc. Filed Acc 0001415889-24-020047
Director bought 8,333,333 shares at $12.00 ($99,999,996)
- Director acquired 461,687 shares (other)
- Director acquired 1,058,282 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
RA CAPITAL MANAGEMENT, L.P. · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-22 | Conversion : show line 1 in the form | +725,391 | 725,391 | I | ||
| 2024-07-22 | Conversion : show line 2 in the form | +264,571 | 264,571 | I | ||
| 2024-07-22 | Conversion : show line 3 in the form | +68,320 | 68,320 | I | ||
| 2024-07-22 | Other acquisition : show line 4 in the form | +323,181 | $10.20 | $3,296,446 | 1,048,572 | I |
| 2024-07-22 | Other acquisition : show line 5 in the form | +138,506 | $10.20 | $1,412,761 | 138,506 | I |
| 2024-07-22 | Purchase : show line 6 in the form | +7,645,007 | $12.00 | $91,740,084 | 8,693,579 | I |
| 2024-07-22 | Purchase : show line 7 in the form | +688,326 | $12.00 | $8,259,912 | 826,832 | I |
| Open-market purchases · 8,333,333 sh · avg $12.00 · $99,999,996 | ||||||
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-22 | Conversion : show line 8 in the form Series A Preferred Stock | −564,372 | 0 | I |
| 2024-07-22 | Conversion : show line 9 in the form Series A Preferred Stock | −210,898 | 0 | I |
| 2024-07-22 | Conversion : show line 10 in the form Series A Preferred Stock | −68,320 | 0 | I |
| 2024-07-22 | Conversion : show line 11 in the form Series B Preferred Stock | −161,019 | 0 | I |
| 2024-07-22 | Conversion : show line 12 in the form Series B Preferred Stock | −53,673 | 0 | I |
Loading xslF345X05/form4-07242024_080707.xml…